March 9, 2015 | Over a 40-year career as a biostatistician specializing in the design of clinical trials, Susan Ellenberg has helped to mainstream and refine such essential principles as full data retention, surrogate endpoints, partnerships with patient advocacy groups, and interim analyses. The Economist